药物基因组学与临床用药的关系(2)
参考文献
[1]杨继单.浅谈遗传与个体化给药. 中国医院学杂志，1998.8(2)：74
[2]Grant SFA. Pharmacogenomics and Pharmacogenomice: tailored drug therapy for 21st century. Trends Pharmacal Sci, 2001, 22(1):3
[3] 何月光，主编.药理学.北京：人民卫生出版社，2006，16
[4] 吴清发，纪佳，董伟.药物基因组学研究进展.生物技术，2002，12(2)：39
[5] 吴俊，何月光主编.治疗学基础.长沙： 湖南科技出版社，2002，397~402
[6] Ahman RB, Klein TE. Challenges for biomedical informatics and pharmacogenomics Annu Rev Pharmacol Toxicol 2002; 42:113~1133.
[7] Claverie JM, Abergel C, Audic S,Ogata H.Recent advances in computational genomics. Pharmacogenomics 2001; 2 (4): 361~372
[8] Kalow W. Pharmacogeneties, pharmacogenomics, and pharmacobiology. Clin Pharmacol Ther 2001; 70(1):1~4
[9] March R.Phannacogenomics: the genomics of drug response yeast, 2000,17(1):16
[10] Sim E, payton M,Noble M,et al.An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and prokaryotes, Hum Mol Genet,2000,9(16):2435
[11] 刘洁，周宏灏。遗传药理学个体化用药的科学依据.中南药学，2007(50)：32~33
[12] Winkelmann BR, Hager J. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics 2000; 1( 1 ): 73~94
[13] 李金恒.高血压的药物基因组学研究与个体化用药的依据。中国处方药，2006，5(50)：16~18
作者单位：410219 长沙医学院, http://www.100md.com(何月光 冷一平 鲍美华)
[1]杨继单.浅谈遗传与个体化给药. 中国医院学杂志，1998.8(2)：74
[2]Grant SFA. Pharmacogenomics and Pharmacogenomice: tailored drug therapy for 21st century. Trends Pharmacal Sci, 2001, 22(1):3
[3] 何月光，主编.药理学.北京：人民卫生出版社，2006，16
[4] 吴清发，纪佳，董伟.药物基因组学研究进展.生物技术，2002，12(2)：39
[5] 吴俊，何月光主编.治疗学基础.长沙： 湖南科技出版社，2002，397~402
[6] Ahman RB, Klein TE. Challenges for biomedical informatics and pharmacogenomics Annu Rev Pharmacol Toxicol 2002; 42:113~1133.
[7] Claverie JM, Abergel C, Audic S,Ogata H.Recent advances in computational genomics. Pharmacogenomics 2001; 2 (4): 361~372
[8] Kalow W. Pharmacogeneties, pharmacogenomics, and pharmacobiology. Clin Pharmacol Ther 2001; 70(1):1~4
[9] March R.Phannacogenomics: the genomics of drug response yeast, 2000,17(1):16
[10] Sim E, payton M,Noble M,et al.An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and prokaryotes, Hum Mol Genet,2000,9(16):2435
[11] 刘洁，周宏灏。遗传药理学个体化用药的科学依据.中南药学，2007(50)：32~33
[12] Winkelmann BR, Hager J. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics 2000; 1( 1 ): 73~94
[13] 李金恒.高血压的药物基因组学研究与个体化用药的依据。中国处方药，2006，5(50)：16~18
作者单位：410219 长沙医学院, http://www.100md.com(何月光 冷一平 鲍美华)